Graeme Bilbe is a seasoned professional in the field of biomedical research with extensive experience spanning over three decades. Currently serving as Senior Advisor and Chief Scientific Officer at the Drugs for Neglected Diseases initiative (DNDi) since June 2012, Bilbe previously held significant roles at Novartis Institutes for BioMedical Research, including Global Head of Neuroscience Discovery and Head of Psychiatric Research, from July 1996 to April 2012. Early career contributions were made at Ciba-Geigy as Head of Cell and Molecular Biology and at Zentrum fuer Molekular Biologie as a Postdoctoral Assistant. Graeme Bilbe holds a PhD in Biochemistry from Imperial College London and a BSc in Zoology/Biochemistry from the University of Nottingham.
This person is not in the org chart